loading

Finanzdaten der Iteos Therapeutics Inc-Aktie (ITOS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 12.60
Operating Expenses
17.65%
47.23
40.15 43.28 42.62 37.52
Depreciation and Amortization
33.92%
0.304
0.227 0.20 0.20 0.222
Operating Income/Loss
17.65%
-47.23
-40.15 -43.28 -42.62 -24.93
Income/Loss From Continuing Operations Before Tax
27.72%
-36.00
-28.19 -33.42 -33.07 -14.35
Income Tax Expense/Benefit
6.31%
2.214
2.363 -1.181 1.232 1.199
Income/Loss From Continuing Operations After Tax
25.09%
-38.22
-30.55 -32.24 -34.30 -15.55
Net Income/Loss
25.09%
-38.22
-30.55 -32.24 -34.30 -15.55
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
496.00K%
35.84
0.00723 35.78 35.77 35.72
Diluted Average Shares
496.00K%
35.84
0.00723 35.78 35.77 35.72
Basic Earnings Per Share
25.88%
-1.07
-0.85 -0.90 -0.96 -0.44
Diluted Earnings Per Share
25.88%
-1.07
-0.85 -0.90 -0.96 -0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):